Medicinal cannabis: the hype is strong, but the evidence is weak.
This week, the UK’s National Institute for Health and Care Excellence declined to approve medicinal cannabis for use in children with severe epilepsy on the NHS, saying there was not enough evidence to support its use. In 2018, however, the US Food and Drug Administration approved a cannabidiol for use in children with two types of severe epilepsy. So what is the situation in Australia, and is there evidence to support all the hype?
